A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

This study has been completed.
Information provided by (Responsible Party):
ClinicalTrials.gov Identifier:
First received: June 25, 2012
Last updated: June 19, 2013
Last verified: June 2013

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Condition Intervention
Glaucoma, Open-Angle
Other: Standard of Care

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Allergan:

Primary Outcome Measures:
  • Change from Baseline in Visual Field [ Time Frame: Baseline, 24 Months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change from Baseline in Intraocular Pressure (IOP) [ Time Frame: Baseline, 24 Months ] [ Designated as safety issue: No ]

Enrollment: 315
Study Start Date: June 2009
Study Completion Date: May 2013
Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients with glaucoma
Other: Standard of Care
Patients with glaucoma treated with standard of care at the discretion of the physician. There is no specific treatment required for this study.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with primary open angle glaucoma in one or both eyes


Inclusion Criteria:

  • Glaucoma in one or both eyes

Exclusion Criteria:

  • Participation in a glaucoma therapeutic clinical trial
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01629407

Barcelona, Spain
Sponsors and Collaborators
Study Director: Medical Director Allergan
  More Information

No publications provided

Responsible Party: Allergan
ClinicalTrials.gov Identifier: NCT01629407     History of Changes
Other Study ID Numbers: MAF/AGN/OPH/GLA/015
Study First Received: June 25, 2012
Last Updated: June 19, 2013
Health Authority: Spain: Ethics Committee

Additional relevant MeSH terms:
Glaucoma, Open-Angle
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on April 17, 2014